These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24875798)

  • 1. Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck.
    Misiukiewicz K; Bonomi M; Demicco E; Posner M
    Ann Oncol; 2014 Aug; 25(8):1667-8. PubMed ID: 24875798
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment options for metastatic head and neck cancer.
    Price KA; Cohen EE
    Curr Treat Options Oncol; 2012 Mar; 13(1):35-46. PubMed ID: 22252884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
    Psyrri A; Rampias T; Vermorken JB
    Ann Oncol; 2014 Nov; 25(11):2101-2115. PubMed ID: 25057165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Khuri FR
    Head Neck; 2013 Mar; 35(3):443-53. PubMed ID: 22052826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Wirth LJ; Dakhil S; Kornek G; Axelrod R; Adkins D; Pant S; O'Brien P; Debruyne PR; Oliner KS; Dong J; Murugappan S
    Oral Oncol; 2016 Oct; 61():31-40. PubMed ID: 27688102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HUMAN PAPILLOMAVIRUS AND SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.
    Cobzeanu MD
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):7-9. PubMed ID: 27125065
    [No Abstract]   [Full Text] [Related]  

  • 7. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck.
    Burtness B
    J Clin Oncol; 2005 Aug; 23(24):5440-2. PubMed ID: 16009959
    [No Abstract]   [Full Text] [Related]  

  • 9. How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
    Szturz P; Seiwert TY; Vermorken JB
    J Clin Oncol; 2017 Jul; 35(20):2229-2231. PubMed ID: 28471725
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy for patients with local-regional recurrent or metastatic carcinoma of the head and neck].
    Dufresne A; Gainet M; Stein U; Guardiola E; Pivot X
    Bull Cancer; 2003 Jan; 90(1):39-45. PubMed ID: 12609803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Rischin D; Spigel DR; Adkins D; Wein R; Arnold S; Singhal N; Lee O; Murugappan S
    Head Neck; 2016 Apr; 38 Suppl 1():E1756-61. PubMed ID: 26681429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study.
    Del Barco Morillo E; Mesía R; Adansa Klain JC; Vázquez Fernández S; Martínez-Galán J; Pastor Borgoñon M; González-Rivas C; Caballero Daroqui J; Berrocal A; Martínez-Trufero J; Vera R; Cruz-Hernández JJ;
    Oral Oncol; 2016 Nov; 62():54-59. PubMed ID: 27865372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma.
    Markovic A; Chung CH
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1149-59. PubMed ID: 23098115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck.
    Rubinstein PG; Lindgren V; Setty S; Yao M; Pytynia KB; Radosevich JA; Kadkol SS; Feldman LE
    J Clin Oncol; 2011 Mar; 29(9):e222-5. PubMed ID: 21189379
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
    J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
    Magnes T; Melchardt T; Weiss L; Mittermair C; Neureiter D; Klieser E; Gampenrieder S; Moser G; Gaggl A; Greil R; Egle A
    PLoS One; 2017; 12(7):e0180995. PubMed ID: 28686697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Greenhalgh J; Bagust A; Boland A; Fleeman N; McLeod C; Dundar Y; Proudlove C; Shaw R
    Health Technol Assess; 2009 Oct; 13 Suppl 3():49-54. PubMed ID: 19846029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-related carcinomas of the head and neck: morphologic features, variants, and practical considerations for the surgical pathologist.
    Stevens TM; Bishop JA
    Virchows Arch; 2017 Aug; 471(2):295-307. PubMed ID: 28417200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for recurrent/metastatic head and neck cancers.
    Karabajakian A; Toussaint P; Neidhardt EM; Paulus V; Saintigny P; Fayette J
    Anticancer Drugs; 2017 Apr; 28(4):357-361. PubMed ID: 28166090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.